세계의 뇌졸중 관리 시장 : 유형별, 용도별 - 기회 분석 및 산업 예측(2022-2032년)
Stroke Management Market By Type (Diagnostics, Therapeutics, Software), By Application (Ischemic Stroke, Haemorrhagic Stroke): Global Opportunity Analysis and Industry Forecast, 2022-2032
상품코드:1414711
리서치사:Allied Market Research
발행일:2023년 11월
페이지 정보:영문 230 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 뇌졸중 관리 시장 규모는 2022년 361억 달러에 달할 것으로 예상되며, 2022-2032년간 연평균 복합 성장률(CAGR) 7.4%로 성장하여 2032년에는 740억 달러에 달할 것으로 예상됩니다.
뇌졸중은 혈관이 터지거나 막혀서 뇌에 혈액 공급이 갑자기 차단되어 뇌에 혈액 공급이 중단되어 발생하는 질환입니다. 그 결과 뇌 조직에 산소가 부족해져 뇌세포가 빠르게 죽게 됩니다. 뇌졸중은 크게 허혈성 뇌졸중, 일과성 뇌허혈 발작, 출혈성 뇌졸중의 세 가지 유형이 있습니다. 뇌졸중의 진단과 치료에 대한 종합적인 접근을 뇌졸중 관리라고 합니다. 뇌졸중 진단에는 자기공명영상, 경동맥 초음파, 뇌혈관조영술, 혈액검사 등이 포함됩니다. 뇌졸중은 조직 플라스미노겐 활성화제, 항응고제, 항혈소판제, 항혈소판제, 항고혈압제 등으로 치료할 수 있습니다.
뇌졸중 관리 시장의 성장은 뇌졸중 발생률 증가, 영상 진단 기술 개발, 뇌졸중 관리를 위한 원격 의료 도입의 급증으로 인해 촉진되고 있습니다.
좌식 생활습관, 건강에 해로운 식습관, 높은 스트레스 수준 등은 뇌졸중 발병률을 높이는 요인으로 작용합니다. 예를 들어, 세계보건기구(WHO)가 2022년 세계 뇌졸중의 날을 맞아 발표한 자료에 따르면, 뇌졸중은 전 세계 사망 원인 중 2위를 차지합니다. 이 자료에 따르면 뇌졸중의 평생 발병 위험은 50% 증가해 현재 4명 중 1명이 평생 뇌졸중을 앓을 것으로 추정됩니다. 이러한 뇌졸중 발병률 증가는 효과적인 치료 및 관리 전략에 대한 수요를 증가시켜 뇌졸중 관리 시장의 성장을 견인하고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 개요
시장 정의와 범위
주요 조사 결과
영향요인
주요 투자 기회
Porter의 Five Forces 분석
시장 역학
성장 촉진요인
성장 억제요인
기회
제4장 뇌졸중 관리 시장 : 유형별
개요
진단
치료제
소프트웨어
제5장 뇌졸중 관리 시장 : 용도별
개요
허혈성 뇌졸중
출혈성 뇌졸중
제6장 뇌졸중 관리 시장 : 지역별
개요
북미
미국
캐나다
멕시코
유럽
독일
프랑스
영국
이탈리아
스페인
기타
아시아태평양
중국
일본
인도
호주
한국
기타
라틴아메리카/중동 및 아프리카
브라질
사우디아라비아
남아프리카공화국
기타
제7장 경쟁 구도
서론
주요 성공 전략
주요 10개사의 제품 매핑
경쟁 대시보드
경쟁 히트맵
주요 기업의 포지셔닝(2022년)
제8장 기업 개요
Abbott Laboratories
B. Braun SE
Boston Scientific Corporation
Bristol-Myers Squibb Company
Cardinal Health
General Electric Company
Medtronic
Siemens AG
JLK
Heuron Co., Ltd.
Deepnoid Co., Ltd.
NeuraSignal, Inc.
Aidoc
Brainomix
METHINKS
Viz.ai, Inc.
iSchemaView, Inc.
Qure.ai
VasSol Inc.
Koninklijke Philips N.V.
Merck & Co. Inc
LSH
영문 목차
영문목차
According to a new report published by Allied Market Research, titled, "Stroke Management Market," The stroke management market was valued at $36.1 billion in 2022, and is estimated to reach $74 billion by 2032, growing at a CAGR of 7.4% from 2022 to 2032.
A stroke is a medical condition that occurs when the blood supply to the brain is abruptly cut off due to rupturing of blood vessels or blockage in blood supply to brain. This leads to depletion of oxygen to brain tissues, which results in the rapid death of brain cells. There are mainly three types of strokes namely ischemic stroke, transient ischemic attack, and hemorrhagic stroke. A comprehensive approach to the diagnosis and treatment of people who suffered from stroke is called stroke management. The diagnosis of stroke includes magnetic resonance imaging, carotid ultrasound, cerebral angiography, blood tests, and others. Stoke can be treated with tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive medicines.
The stroke management market growth is driven by rising incidence of stroke, technological development in diagnostic imaging, and surge in adoption of telemedicine for stroke management. Factors such as
1) sedentary lifestyle, unhealthy diets, and high stress levels leads to rise in incidences of stroke. For instance, according to the data published by World Health Organization (WHO), on World Stroke Day 2022, reported that stroke is the second leading cause of death across the globe. As per the same source, the lifetime risk of developing a stroke has increased by 50% and currently 1 in 4 people is estimated to have a stroke in their lifetime. This rise in stroke incidences has led to a higher demand for effective treatments and management strategies, which in turn drives the growth of the stroke management market.
In addition, the technological advancement in the diagnostic techniques also drives the market growth. The advanced imaging technologies such as
1) magnetic resonance imaging and angiography systems have improved the diagnosis of stroke and enhanced patient care. For instance, Siemens Healthineers, a global medical technology company has received the Food and Drug Administration (FDA) approval for its ARTIS icono ceiling. ARTIS icono ceiling is an angiography system used for the advanced procedures in the interventional cardiology. Thus, technological advancement in the stroke imaging techniques further boost the market growth.
However, the high cost of stroke diagnosis and treatment limit the growth of stroke management market. The economic burden of stroke is the major factor hampering the market growth. For instance, according to World Stroke Organization (WSO), the Lancet Public Health article estimated treatment, rehabilitation, and indirect costs for stroke is more than $700 billion annually. Thus, high diagnosis and treatment cost negatively impact the growth of stroke management market.
On the other hand, surge in adoption of artificial intelligence for stroke management, increase in awareness about preventive healthcare, and rise in geriatric population in developing countries are expected to create lucrative opportunities for market growth during the forecast period.
The stroke management market is segmented on the basis of type, application, and region. On the basis of type, the market is classified into diagnostics, therapeutics, and software. The diagnostic segment is further categorized into magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. The therapeutics segment is further divided into tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive. As per application, the market is bifurcated into ischemic stroke and hemorrhagic stroke.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global stroke management market are Abbott Laboratories, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, General Electric Company, Medtronic, Siemens AG, Aidoc, Brainomix, VasSol Inc., Qure.ai, Viz.ai, Inc., METHINKS, B Braun SE, iSchemaView, Inc., NeuraSignal, Inc., Deepnoid Co., Ltd., Heuron Co., Ltd., JLK, Koninklijke Philips N.V., and Merck & Co. Inc. Key players operating in the market have adopted product approval, acquisition, partnership, and product launch as their key strategies to expand their market share and product portfolio.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the stroke management market analysis from 2022 to 2032 to identify the prevailing stroke management market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the stroke management market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global stroke management market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
SWOT Analysis
Key Market Segments
By Type
Diagnostics
Type
Magnetic Resonance Imaging
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
Therapeutics
Type
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Software
By Application
Ischemic Stroke
Haemorrhagic Stroke
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players:
Boston Scientific Corporation
Bristol-Myers Squibb Company
General Electric Company
Medtronic
Aidoc
Brainomix
Qure.ai
METHINKS
iSchemaView, Inc.
Deepnoid Co., Ltd.
Heuron Co., Ltd.
B. Braun SE
Koninklijke Philips N.V.
Abbott Laboratories
Cardinal Health
Siemens AG
VasSol Inc.
Viz.ai, Inc.
NeuraSignal, Inc.
JLK
Merck & Co. Inc
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in the incidences of stroke
3.4.1.2. Technological development in stroke management
3.4.1.3. Significant increase in stroke awareness
3.4.2. Restraints
3.4.2.1. High cost of stroke diagnostics and treatment
3.4.3. Opportunities
3.4.3.1. Artificial intelligence and machine learning are revolutionizing stroke management
CHAPTER 4: STROKE MANAGEMENT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Diagnostics
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Diagnostics Stroke Management Market by Type
4.3. Therapeutics
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Therapeutics Stroke Management Market by Type
4.4. Software
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: STROKE MANAGEMENT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Ischemic Stroke
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Haemorrhagic Stroke
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: STROKE MANAGEMENT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Type
6.2.4.1.2. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Type
6.2.4.2.2. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Type
6.2.4.3.2. Market size and forecast, by Application
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Type
6.3.4.1.2. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Type
6.3.4.2.2. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Type
6.3.4.3.2. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Type
6.3.4.4.2. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Type
6.3.4.5.2. Market size and forecast, by Application
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Type
6.3.4.6.2. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Market size and forecast, by Type
6.4.4.1.2. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Market size and forecast, by Type
6.4.4.2.2. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Type
6.4.4.3.2. Market size and forecast, by Application
6.4.4.4. Australia
6.4.4.4.1. Market size and forecast, by Type
6.4.4.4.2. Market size and forecast, by Application
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Type
6.4.4.5.2. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Type
6.4.4.6.2. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Type
6.5.4.1.2. Market size and forecast, by Application
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Type
6.5.4.2.2. Market size and forecast, by Application
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Type
6.5.4.3.2. Market size and forecast, by Application
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Type
6.5.4.4.2. Market size and forecast, by Application
